2,6-Diisopropylphenol

Papers

Synthesis, structure-activity relationships at the GABA(A) receptor in rat brain, and differential electrophysiological profile at the recombinant human GABA(A) receptor of a series of substituted 1,2-diphenylimidazoles. Battistina Asproni et al J. Med. Chem. 48, 2638-45, (2005)

---

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. Didier M Lambert et al J. Med. Chem. 48, 5059-87, (2005)

---

Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study. Cynthia D Selassie et al J. Med. Chem. 48, 7234-42, (2005)

---

UDP-glucuronosyltransferases and clinical drug-drug interactions. Tony K L Kiang et al Pharmacol. Ther. 106, 97-132, (2005)

---

Chemical genetics reveals a complex functional ground state of neural stem cells Diamandis, P., et. al. Nat. Chem. Biol. 3(5), 268-273, (2007)

---

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Gustav Ahlin et al J. Med. Chem. 51, 5932-42, (2008)

---

Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors. Mark Seierstad et al J. Med. Chem. 51, 7327-43, (2008)

---

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. R Scott Obach et al Drug Metab. Dispos. 36, 1385-405, (2008)

---

Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Murat Sentürk et al Bioorg. Med. Chem. 17, 3207-11, (2009)

---

Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds. Jerry O Ebalunode et al Bioorg. Med. Chem. 17, 5133-8, (2009)

---

Comparative molecular field analysis and synthetic validation of a hydroxyamide-propofol binding and functional block of neuronal voltage-dependent sodium channels. Milton L Brown et al Bioorg. Med. Chem. 17, 7056-63, (2009)

---

m-Azipropofol (AziPm) a photoactive analogue of the intravenous general anesthetic propofol. Michael A Hall et al J. Med. Chem. 53, 5667-75, (2010)

---

Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells. Kevin A Harvey et al Bioorg. Med. Chem. 18, 1866-74, (2010)

---

Developing structure-activity relationships for the prediction of hepatotoxicity. Nigel Greene et al Chem. Res. Toxicol. 23, 1215-22, (2010)

---

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Denis Fourches et al Chem. Res. Toxicol. 23, 171-83, (2010)

---

A predictive ligand-based Bayesian model for human drug-induced liver injury. Sean Ekins et al Drug Metab. Dispos. 38, 2302-8, (2010)

---

Synthesis and characterization of novel PUFA esters exhibiting potential anticancer activities: an in vitro study. Azmat Ali Khan et al Eur. J. Med. Chem. 46, 4878-86, (2011)

---

Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps). Zhichao Liu et al PLoS Comput. Biol. 7, e1002310, (2011)

---

Merck 14,7834

Beil. 6,I,272

Aldrich MSDS 1, 724:A / Corp MSDS 1 (1), 1298:B / FT-IR 2 (2), 1851:A / FT-IR 1 (1), 1082:A / FT-NMR 1 (2), 258:C / IR-Spectra (2), 579:H / IR-Spectra (3), 650:E / NMR-Reference 2 (1), 876:D / RegBook 1 (1), 1273:L / Sax 6, 1089 / Structure Index 1, 193:C:8 / Vapor Phase 3, 1014:C